Treatment of neurofibromas with a carbon dioxide laser: a retrospective cross-sectional study of 106 patients.

Background: Few studies have evaluated the efficacy of carbon dioxide (CO2) laser ablation for treating neurofibromatosis type 1 (NF1).

Objective: To evaluate laser treatment safety and patient satisfaction at the French National Referral Centre for Neurofibromatosis.

Methods: Retrospective survey with a specific questionnaire.

Dermatosurgery: total quality management in a dermatology department.

Background: Dermatosurgery (DS) is a growing sector in dermatology. Performance measurement is organized worldwide to improve the quality of health care. Clinical audit relies on self-assessment, comparison with guidelines, frames of references and implementation of improvement actions.

Nevus of Ota in dark skin--an uncommon but treatable entity.

Background: Nevus of Ota can be effectively and safely treated since the arrival of q-switched lasers in dermatology. However, available literature is scarce regarding the treatment of Nevus of Ota in skin types darker than IV.

Objectives: We report about four Fitzpatrick phototype V patients treated for Nevus of Ota with a q-switched Nd:YAG laser at 1,064 nm.

[Granuloma with lymphocytic hyperplasia following vaccination: 10 cases. Presence of aluminium in the biopsies].

Background: Few cases of cutaneous lymphocytic hyperplasia secondary to vaccination have been published, although such lesions are not rare.

Patients And Methods: We report a series of 10 cases registered between 1993 and 2003.

Results: Mean age was 25.

[Seizures during interferon alpha therapy: three cases in dermatology].

Introduction: Interferon alpha has many side effects. Among them the risk of occurrence of seizures is not well known by dermatologists. We report three cases of seizures that occurred in patients treated with interferon alpha in two dermatological diseases: mycosis fungoides and melanoma.